419 related articles for article (PubMed ID: 20012964)
1. The diagnostic utilities of anti-agalactosyl IgG antibodies, anti-cyclic citrullinated peptide antibodies, and rheumatoid factors in rheumatoid arthritis.
Ryu HJ; Takeuchi F; Kuwata S; Kim YJ; Lee EY; Lee EB; Song YW
Rheumatol Int; 2011 Mar; 31(3):315-9. PubMed ID: 20012964
[TBL] [Abstract][Full Text] [Related]
2. Comparison of anti-agalactosyl IgG antibodies, rheumatoid factors, and anti-cyclic citrullinated peptide antibodies in the differential diagnosis of rheumatoid arthritis and its mimics.
Lu MC; Hsieh SC; Lai NS; Li KJ; Wu CH; Yu CL
Clin Exp Rheumatol; 2007; 25(5):716-21. PubMed ID: 18078619
[TBL] [Abstract][Full Text] [Related]
3. Anti-agalactosyl IgG antibodies in Thai patients with rheumatoid arthritis, systemic lupus erythematosus, and systemic sclerosis.
Louthrenoo W; Kasitanon N; Wichainun R; Wangkaew S; Sukitawut W; Kuwata S; Takeuchi F
Clin Rheumatol; 2010 Mar; 29(3):241-6. PubMed ID: 20091076
[TBL] [Abstract][Full Text] [Related]
4. Anticyclic citrullinated peptide antibodies in rheumatoid and nonrheumatoid rheumatic disorders: experience with 1162 patients.
Payet J; Goulvestre C; Bialé L; Avouac J; Wipff J; Job-Deslandre C; Batteux F; Dougados M; Kahan A; Allanore Y
J Rheumatol; 2014 Dec; 41(12):2395-402. PubMed ID: 25274898
[TBL] [Abstract][Full Text] [Related]
5. Rheumatoid factor and anti-cyclic citrullinated peptide (anti-CCP) antibodies with hepatitis B and hepatitis C infection: Review.
Zengin O; Yıldız H; Demir ZH; Dağ MS; Aydınlı M; Onat AM; Kısacık B
Adv Clin Exp Med; 2017 Sep; 26(6):987-990. PubMed ID: 29068601
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic utility of anti-cyclic citrullinated peptide antibodies for very early rheumatoid arthritis.
Matsui T; Shimada K; Ozawa N; Hayakawa H; Hagiwara F; Nakayama H; Sugii S; Ozawa Y; Tohma S
J Rheumatol; 2006 Dec; 33(12):2390-7. PubMed ID: 16924694
[TBL] [Abstract][Full Text] [Related]
7. Relationship between rheumatoid factor isotypes and IgG anti-cyclic citrullinated peptide antibodies.
Jaskowski TD; Hill HR; Russo KL; Lakos G; Szekanecz Z; Teodorescu M
J Rheumatol; 2010 Aug; 37(8):1582-8. PubMed ID: 20516016
[TBL] [Abstract][Full Text] [Related]
8. Clinical evaluation of anti-mutated citrullinated vimentin by ELISA in rheumatoid arthritis.
Soós L; Szekanecz Z; Szabó Z; Fekete A; Zeher M; Horváth IF; Dankó K; Kapitány A; Végvári A; Sipka S; Szegedi G; Lakos G
J Rheumatol; 2007 Aug; 34(8):1658-63. PubMed ID: 17611988
[TBL] [Abstract][Full Text] [Related]
9. Anti-agalactosyl IgG antibodies and isotype profiles of rheumatoid factors in Sjögren's syndrome and rheumatoid arthritis.
Ichikawa Y; Yamada C; Horiki T; Hoshina Y; Uchiyama M; Yamada Y; Toumatu J
Clin Exp Rheumatol; 1998; 16(6):709-15. PubMed ID: 9844764
[TBL] [Abstract][Full Text] [Related]
10. Association of anti-cyclic citrullinated peptide antibodies, anti-citrullin antibodies, and IgM and IgA rheumatoid factors with serological parameters of disease activity in rheumatoid arthritis.
Greiner A; Plischke H; Kellner H; Gruber R
Ann N Y Acad Sci; 2005 Jun; 1050():295-303. PubMed ID: 16014545
[TBL] [Abstract][Full Text] [Related]
11. Anti-CCP and antikeratin antibodies in rheumatoid arthritis, primary Sjögren's syndrome, and Wegener's granulomatosis.
Kamali S; Polat NG; Kasapoglu E; Gul A; Ocal L; Aral O; Konice M; Badur S; Inanc M
Clin Rheumatol; 2005 Nov; 24(6):673-6. PubMed ID: 15926038
[TBL] [Abstract][Full Text] [Related]
12. Anti-cyclic citrullinated peptide antibodies distinguish hepatitis B virus (HBV)-associated arthropathy from concomitant rheumatoid arthritis in patients with chronic HBV infection.
Lim MK; Sheen DH; Lee YJ; Mun YR; Park M; Shim SC
J Rheumatol; 2009 Apr; 36(4):712-6. PubMed ID: 19286846
[TBL] [Abstract][Full Text] [Related]
13. Usefulness of anti-CCP antibodies in patients with hepatitis C virus infection with or without arthritis, rheumatoid factor, or cryoglobulinemia.
Liu FC; Chao YC; Hou TY; Chen HC; Shyu RY; Hsieh TY; Chen CH; Chang DM; Lai JH
Clin Rheumatol; 2008 Apr; 27(4):463-7. PubMed ID: 17876647
[TBL] [Abstract][Full Text] [Related]
14. Anti-cyclic citrullinated peptide, rheumatoid factor, and ocular symptoms typical of rheumatoid arthritis.
Itty S; Pulido JS; Bakri SJ; Baratz KH; Matteson EL; Hodge DO
Trans Am Ophthalmol Soc; 2008; 106():75-81; discussion 81-3. PubMed ID: 19277223
[TBL] [Abstract][Full Text] [Related]
15. Anti-cyclic citrullinated peptide antibodies and rheumatoid factor in leprosy patients with articular involvement.
Ribeiro SL; Pereira HL; Silva NP; Neves RM; Sato EI
Braz J Med Biol Res; 2008 Nov; 41(11):1005-10. PubMed ID: 19099154
[TBL] [Abstract][Full Text] [Related]
16. [New diagnostic and evaluative tests for rheumatoid arthritis].
Hayashi N; Nishimura K; Morinobu A; Kumagai S
Rinsho Byori; 2007 Apr; 55(4):388-96. PubMed ID: 17511271
[TBL] [Abstract][Full Text] [Related]
17. A comparative study of IgG second- and third-generation anti-cyclic citrullinated peptide (CCP) ELISAs and their combination with IgA third-generation CCP ELISA for the diagnosis of rheumatoid arthritis.
dos Anjos LM; Pereira IA; d 'Orsi E; Seaman AP; Burlingame RW; Morato EF
Clin Rheumatol; 2009 Feb; 28(2):153-8. PubMed ID: 18795390
[TBL] [Abstract][Full Text] [Related]
18. Anti-cyclic citrullinated peptide antibody in systemic sclerosis.
Morita Y; Muro Y; Sugiura K; Tomita Y
Clin Exp Rheumatol; 2008; 26(4):542-7. PubMed ID: 18799082
[TBL] [Abstract][Full Text] [Related]
19. [Detection of antibodies to cyclic citrullinated peptides and its clinical significance in patients with chronic hepatitis B virus infection].
Zhou RF; Liu XF; Chen Y; Wu F; Zeng AP; Cheng YJ
Zhonghua Yi Xue Za Zhi; 2012 Jun; 92(22):1536-9. PubMed ID: 22944056
[TBL] [Abstract][Full Text] [Related]
20. [Diagnostic value of serum anti-cyclic citrullinated peptide antibodies in patients with rheumatoid arthritis].
Yang CL; Zhou YR; Zhou F; Li J
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Aug; 27(8):1277-9. PubMed ID: 17715048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
